• Tue, September 17, 2024
Oren Livnat Reiterated (ANIP) at Strong Buy and Held Target at $94 on, Sep 17th, 2024
Oren Livnat of HC Wainwright & Co., Reiterated "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy and Held Target at $94 on, Sep 17th, 2024.
Oren has made no other calls on ANIP in the last 4 months.
There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, all agrees with Oren's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gregory Fraser of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $60 on, Wednesday, September 11th, 2024
Like: 👍
